Cerevel Therapeutics Hldng I shares owned by Citadel Advisors
Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Cerevel Therapeutics Hldng I
Tip: Access up to 7 years of quarterly data
All positions including Cerevel Therapeutics Hldng I held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cerevel Therapeutics Hldng I by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $16M | 369k | 42.40 |
| 2023-09-30 | $4.2M | 193k | 21.83 |
| 2023-06-30 | $5.4M | 171k | 31.79 |
| 2023-03-31 | $2.8M | 116k | 24.39 |
| 2022-12-31 | $2.1M | 68k | 31.54 |
| 2022-06-30 | $14M | 517k | 26.44 |
| 2022-03-31 | $2.2M | 64k | 35.01 |
| 2021-12-31 | $14M | 423k | 32.42 |
| 2021-09-30 | $20M | 681k | 29.50 |
| 2021-06-30 | $26M | 996k | 25.62 |
| 2021-03-31 | $17M | 1.2M | 13.67 |
| 2020-12-31 | $23M | 1.4M | 16.58 |